{
    "paper_id": "PMC7235519",
    "metadata": {
        "title": "\nCOVID\u201019 and SARS: Differences and similarities",
        "authors": [
            {
                "first": "Antonio",
                "middle": [],
                "last": "Caldaria",
                "suffix": "",
                "email": null,
                "affiliation": {}
            },
            {
                "first": "Claudio",
                "middle": [],
                "last": "Conforti",
                "suffix": "",
                "email": null,
                "affiliation": {}
            },
            {
                "first": "Nicola",
                "middle": [],
                "last": "Di Meo",
                "suffix": "",
                "email": null,
                "affiliation": {}
            },
            {
                "first": "Caterina",
                "middle": [],
                "last": "Dianzani",
                "suffix": "",
                "email": null,
                "affiliation": {}
            },
            {
                "first": "Mohammad",
                "middle": [],
                "last": "Jafferany",
                "suffix": "",
                "email": null,
                "affiliation": {}
            },
            {
                "first": "Torello",
                "middle": [],
                "last": "Lotti",
                "suffix": "",
                "email": null,
                "affiliation": {}
            },
            {
                "first": "Iris",
                "middle": [],
                "last": "Zalaudek",
                "suffix": "",
                "email": null,
                "affiliation": {}
            },
            {
                "first": "Roberta",
                "middle": [],
                "last": "Giuffrida",
                "suffix": "",
                "email": "roberta_giuffrida@hotmail.it",
                "affiliation": {}
            }
        ]
    },
    "body_text": [
        {
            "text": "SARS\u2010CoV (causative pathogen of Severe Acute Respiratory Syndrome or SARS) and SARS\u2010CoV\u20102 (causative pathogen of Coronavirus Disease 2019 or COVID\u201019) are positive\u2010sense RNA viruses belonging to the family of Coronaviridae, able to cause severe respiratory diseases.1, 2, 3, 4\n",
            "cite_spans": [],
            "section": "",
            "ref_spans": []
        },
        {
            "text": "Despite some similarities, they have many differences, especially in terms of epidemiology. The main differences and similarities are summarized in Table 1.",
            "cite_spans": [],
            "section": "",
            "ref_spans": [
                {
                    "start": 154,
                    "end": 155,
                    "mention": "1",
                    "ref_id": "TABREF0"
                }
            ]
        },
        {
            "text": "Genomic characterization has shown that SARS\u2010CoV\u20102 share almost 80% of the genome with SARS\u2010CoV but it contains additional gene regions (10b, 13, 14).\n5\n\n",
            "cite_spans": [],
            "section": "",
            "ref_spans": []
        },
        {
            "text": "SARS originated in China's Guangdong province on November 27, 2002. It presented as a respiratory disease caused by the SARS coronavirus (SARS\u2010CoV). At the end of the epidemic in June, the infection affected 8422 individuals leading to 916 deaths and a case\u2010fatality ratio of 10.9% across 29 countries.\n2\n\n",
            "cite_spans": [],
            "section": "",
            "ref_spans": []
        },
        {
            "text": "On the other hand, COVID\u201019 began in Wuhan (China), the largest city in Hubei province, in central China in the last week of December 2019. To date, a cumulative 512 701 cases with 23 495 deaths (case\u2010fatality ratio of 4,6%) were reported across 202 countries\n6\n and, based on available data, the transmission rate might be higher for COVID\u201019 than for SARS.",
            "cite_spans": [],
            "section": "",
            "ref_spans": []
        },
        {
            "text": "The incubation period for SARS was from 2 to 10 days (with mean of 4\u20105 days) while the average incubation period for COVID\u201019 is 5.1 days, with a range of 1 to14 days. The average latency of COVID is slightly longer than SARS.\n4\n\n",
            "cite_spans": [],
            "section": "",
            "ref_spans": []
        },
        {
            "text": "The World Health Organization (WHO) estimates an average basic reproduction number (R0) of COVID\u201019 of 1.4 to 2.5, with a median of 1.95. In other words, each patient transmits the infection to an additional 1.95 people. The R0 of the SARS epidemic were approximately 3.\n3\n In contrast with these values, a study shows that the COVID\u201019 is already more widespread than SARS because its real average R0 is 3.28.\n7\n This data indicates that COVID\u201019 may be more transmissible than SARS.",
            "cite_spans": [],
            "section": "",
            "ref_spans": []
        },
        {
            "text": "There was a predominance of female patients affected by SARS, with a male to female ratio of 1:1.25. Instead COVID\u201019 is much more prevalent among males, with a male to female ratio of 2.7:1.\n8\n Data show that the COVID\u201019 patients' median age is 59 years, with a range of 15 to 89 years while the median age of patients with SARS was 35 years, with a range of 0 to 92 years and the highest age\u2010specific incidence was in patients with 65\u201069 years.\n2\n\n",
            "cite_spans": [],
            "section": "",
            "ref_spans": []
        },
        {
            "text": "The early symptoms of SARS and COVID\u201019 are very similar, including fever, cough, headache, shortness breath and breathing difficulties. Diarrhea was reported in about 20\u201025% of patients with SARS, while intestinal symptoms were rarely described in patients with COVID\u201019. In addition, most patients with SARS and COVID\u201019 developed lymphopenia with high\u2010levels of proinflammatory cytokines including interleukin (IL)\u20101b and IL\u20106.\n2\n\n",
            "cite_spans": [],
            "section": "",
            "ref_spans": []
        },
        {
            "text": "The possible pathogens are both derived from wild animals: SARS\u2010CoV was transmitted from civet cats to humans. Previous studies showed that bats were the most likely reservoir for SARS\u2010CoV\u20102 as it is very similar to a bat coronavirus.\n8\n However, there are no evidences of direct bat\u2010human transmission; instead pangolins are the possible intermediate host for COVID\u201019. The common aspect is that SARS and COVID\u201019 infect lung alveolar epithelial cells using receptor\u2010mediated endocytosis via the angiotensin\u2010converting enzyme II (ACE2) as an entry receptor.\n9\n\n",
            "cite_spans": [],
            "section": "",
            "ref_spans": []
        },
        {
            "text": "The rapid development of this pandemic requires comparisons with previous epidemic, to analyze infection trends and to find the right prevention and treatment measures, as was done in the past for similar cases.",
            "cite_spans": [],
            "section": "",
            "ref_spans": []
        },
        {
            "text": "The authors declare no potential conflict of interest.",
            "cite_spans": [],
            "section": "CONFLICT OF INTEREST",
            "ref_spans": []
        }
    ],
    "ref_entries": {
        "TABREF0": {
            "text": "TABLE 1: Main aspects of coronavirus disease 2019 (COVID\u201019) and severe acute respiratory syndrome (SARS)\n",
            "type": "table"
        }
    },
    "back_matter": [],
    "bib_entries": {
        "BIBREF0": {
            "title": "COVID\u201019 and psoriasis: is it time to limit treatment with immunosuppressants? A call for action",
            "authors": [],
            "year": 2020,
            "venue": "Dermatol Ther",
            "volume": "11",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": [
                    "10.1111/dth.13298"
                ]
            }
        },
        "BIBREF1": {
            "title": "Immune responses in COVID\u201019 and potential vaccines: lessons learned from SARS and MERS epidemic",
            "authors": [],
            "year": 2020,
            "venue": "Asian Pac J Allergy Immunol",
            "volume": "38",
            "issn": "",
            "pages": "1-9",
            "other_ids": {
                "DOI": [
                    "10.12932/AP-200220-0772"
                ]
            }
        },
        "BIBREF2": {
            "title": "",
            "authors": [],
            "year": 2020,
            "venue": "Features, Evaluation and Treatment Coronavirus (COVID\u201019)",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF3": {
            "title": "Learning from history: coronavirus outbreaks in the past",
            "authors": [],
            "year": 2020,
            "venue": "Dermatol Ther",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": [
                    "10.1111/dth.13343"
                ]
            }
        },
        "BIBREF4": {
            "title": "Genomic characterization of the 2019 novel human\u2010pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan",
            "authors": [],
            "year": 2020,
            "venue": "Emerg Microbes Infect",
            "volume": "9",
            "issn": "",
            "pages": "221-236",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF5": {
            "title": "",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF6": {
            "title": "The reproductive number of COVID\u201019 is higher compared to SARS coronavirus",
            "authors": [],
            "year": 2020,
            "venue": "J Travel Med",
            "volume": "27",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": [
                    "10.1093/jtm/taaa021"
                ]
            }
        },
        "BIBREF7": {
            "title": "Systematic comparison of two animal\u2010to\u2010human transmitted human coronaviruses: SARS\u2010CoV\u20102 and SARS\u2010CoV",
            "authors": [],
            "year": 2020,
            "venue": "Viruses",
            "volume": "12",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": [
                    "10.3390/v12020244"
                ]
            }
        },
        "BIBREF8": {
            "title": "The COVID\u201019 epidemic",
            "authors": [],
            "year": 2020,
            "venue": "Trop Med Int Health",
            "volume": "25",
            "issn": "",
            "pages": "278-280",
            "other_ids": {
                "DOI": [
                    "10.1111/tmi.13383"
                ]
            }
        }
    }
}